InnoCare Pharma Limited (INCPF)

PNK: INCPF · Real-Time Price · USD

3.26

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

InnoCare Pharma Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	1.01B	738.54M	625.4M	1.04B	1.36M	1.25M	1.62M	102K
Cost of Revenue	138.44M	128.44M	143.4M	65.67M	39.26M	33.74M	n/a	n/a
Gross Profit	871.01M	610.1M	482.01M	977.37M	-37.89M	-32.5M	1.62M	102K
Operating Income	-525.78M	-651.15M	-891.63M	-24.25M	-464.89M	-2.15B	-553.91M	-340.14M
Interest Income	171.59M	192.33M	136.91M	135.13M	96.81M	72.05M	8.42M	213K
Pretax Income	-452.59M	-644.21M	-893.73M	-20.12M	-464.26M	-2.15B	-554.02M	-341.73M
Net Income	-440.63M	-631.26M	-886.59M	-64.55M	-463.79M	-2.14B	-549.95M	-341.73M
Selling & General & Admin	310.64M	551.28M	489.61M	344.66M	113.15M	36.12M	6.36M	4.24M
Research & Development	814.03M	757.25M	639.14M	721.58M	402.77M	213.12M	149.73M	62.88M
Other Expenses	272.12M	-47.28M	-287.69M	-52.28M	-175.44M	-1.97B	-415.78M	-272.69M
Operating Expenses	1.4B	1.26B	1.21B	1.14B	495.91M	251.88M	150.26M	67.12M
Interest Expense	33.79M	35.03M	17.05M	2.64M	1.14M	938K	1.45M	2.4M
Selling & Marketing Expenses	262.77M	366.89M	438.61M	298.46M	68.21M	3.46M	558K	n/a
Cost & Expenses	1.54B	1.39B	1.36B	1.21B	495.91M	251.88M	150.26M	67.12M
Income Tax Expense	263K	1.43M	-7.13M	46.56M	-470K	-8.96M	-4.07M	n/a
Shares Outstanding (Basic)	1.69B	1.71B	1.48B	1.76B	967.58M	1.76B	1.25B	1.25B
Shares Outstanding (Diluted)	1.69B	1.71B	1.48B	1.76B	967.58M	1.76B	1.25B	1.25B
EPS (Basic)	-0.26	-0.37	-0.6	-0.04	-0.48	-1.21	-0.44	-0.27
EPS (Diluted)	-0.26	-0.37	-0.6	-0.04	-0.48	-1.21	-0.44	-0.27
EBITDA	-312.55M	-516.55M	-808.28M	16.23M	-453.44M	-2.14B	-547.19M	-335.61M
EBIT	-418.81M	-609.17M	-876.68M	-17.48M	-390.73M	-2.15B	-552.58M	-339.33M
Depreciation & Amortization	106.26M	92.62M	68.4M	32.48M	11.45M	9.07M	5.39M	3.72M